Evidence map›Paper›PMID 37725216›Full record

ReviewMolecular neurobiology2024

Oxytosis/Ferroptosis in Neurodegeneration: the Underlying Role of Master Regulator Glutathione Peroxidase 4 (GPX4).

Nawab John Dar, Urmilla John, Nargis Bano, Sameera Khan, Shahnawaz Ali Bhat

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Redox Molecules in Aging and Neurodegenerative Disorders.International journal of molecular sciences · 2026
    Review
  5. Observational
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Unlocking the Neuroprotective Potential ofAntioxidants (Basel, Switzerland) · 2026
    Review
  13. Neurodegenerative Diseases in Children: A Comprehensive Review.International journal of molecular sciences · 2026
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Programmed cell death pathways in huntington's disease: spotlight on ferroptosis and pyroptosis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nawab John DarSchool of Medicine, University of Texas Health San Antonio, San Antonio, TX, 78229, USA. nawabdar@gmail.com.
Urmilla JohnSchool of Studies in Neuroscience, Jiwaji University, Gwalior, India.
Nargis BanoFaculty of Life Sciences, Department of Zoology, Aligarh Muslim University, Aligarh, U.P, India.
Sameera KhanFaculty of Life Sciences, Department of Zoology, Aligarh Muslim University, Aligarh, U.P, India.
Shahnawaz Ali BhatFaculty of Life Sciences, Department of Zoology, Aligarh Muslim University, Aligarh, U.P, India. sabhat1@myamu.ac.in.ORCID http://orcid.org/0000-0003-4098-8810

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxytosis/ferroptosis is an iron-dependent oxidative form of cell death triggered by lethal accumulation of phospholipid hydroperoxides (PLOOHs) in membranes. Failure of the intricate PLOOH repair system is a principle cause of ferroptotic cell death. Glutathione peroxidase 4 (GPX4) is distinctly vital for converting PLOOHs in membranes to non-toxic alcohols. As such, GPX4 is known as the master regulator of oxytosis/ferroptosis. Ferroptosis has been implicated in a number of disorders such as neurodegenerative diseases (amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD), etc.), ischemia/reperfusion injury, and kidney degeneration. Reduced function of GPX4 is frequently observed in degenerative disorders. In this study, we examine how diminished GPX4 function may be a critical event in triggering oxytosis/ferroptosis to perpetuate or initiate the neurodegenerative diseases and assess the possible therapeutic importance of oxytosis/ferroptosis in neurodegenerative disorders. These discoveries are important for advancing our understanding of neurodegenerative diseases because oxytosis/ferroptosis may provide a new target to slow the course of the disease.

Indexed as

FerroptosisNeurodegenerative DiseasesCell DeathGlutathioneGlutathione PeroxidaseHumansLipid PeroxidationOxidation-ReductionPhospholipid Hydroperoxide Glutathione PeroxidaseGlutathioneGlutathione PeroxidasePhospholipid Hydroperoxide Glutathione PeroxidaseADALSGPX4Lipid peroxidationNeurodegenerationOxidative stressOxytosis/ferroptosisPD

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.